NEW YORK STATE COMMON RETIREMENT FUND - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 99 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,423
-28.2%
16,594
+13.7%
0.00%
-25.0%
Q2 2023$3,373
-20.4%
14,600
-16.6%
0.00%
-33.3%
Q1 2023$4,240
-32.4%
17,502
-19.0%
0.01%
-33.3%
Q4 2022$6,273
-99.5%
21,613
+22.9%
0.01%
+350.0%
Q3 2022$1,143,000
-9.0%
17,589
+0.2%
0.00%0.0%
Q2 2022$1,256,000
+52.2%
17,553
+108.8%
0.00%
+100.0%
Q1 2022$825,000
+18.7%
8,406
+2.6%
0.00%0.0%
Q4 2021$695,000
+5.9%
8,196
-0.3%
0.00%0.0%
Q3 2021$656,000
-31.8%
8,218
-16.7%
0.00%0.0%
Q2 2021$962,000
+1.6%
9,871
+21.9%
0.00%0.0%
Q1 2021$947,000
+5.2%
8,1000.0%0.00%0.0%
Q4 2020$900,000
-6.4%
8,1000.0%0.00%0.0%
Q3 2020$962,000
+4.9%
8,1000.0%0.00%0.0%
Q2 2020$917,000
+76.0%
8,100
+3.8%
0.00%0.0%
Q1 2020$521,000
-26.7%
7,8000.0%0.00%0.0%
Q4 2019$711,000
-9.4%
7,800
-14.3%
0.00%0.0%
Q3 2019$785,000
-7.5%
9,100
+12.3%
0.00%0.0%
Q2 2019$849,000
-4.5%
8,100
+14.1%
0.00%0.0%
Q1 2019$889,000
+11.1%
7,1000.0%0.00%0.0%
Q4 2018$800,000
-51.5%
7,100
-7.8%
0.00%
-50.0%
Q3 2018$1,649,000
-9.3%
7,700
+18.5%
0.00%0.0%
Q2 2018$1,818,000
+245.6%
6,500
+44.4%
0.00%
+100.0%
Q1 2018$526,000
+27.4%
4,5000.0%0.00%
Q4 2017$413,000
+37.2%
4,500
-32.8%
0.00%
Q3 2017$301,000
+176.1%
6,7000.0%0.00%
Q2 2017$109,0006,7000.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 463,000$99,142,0004.55%
Rock Springs Capital Management LP 342,000$73,232,0002.65%
ACUTA CAPITAL PARTNERS, LLC 33,000$7,066,0002.52%
HealthCor Management, L.P. 262,860$56,286,0001.87%
Baker Brothers Advisors 1,169,278$250,377,0001.65%
EMORY UNIVERSITY 11,391$2,439,0001.60%
PACIFIC VIEW ASSET MANAGEMENT, LLC 8,690$1,862,0001.48%
GREAT POINT PARTNERS LLC 40,400$8,651,0001.35%
SHIKIAR ASSET MANAGEMENT INC 15,341$3,285,0001.28%
ARMISTICE CAPITAL, LLC 80,000$17,130,0001.03%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders